© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 13, 2022
Strict utilization management policies have led some patients to make decisions like skipping medication doses.
June 03, 2022
Regeneron Pharmaceuticals Inc came to an agreement to buy the drug from Sanofi for up to $1.1 billion.
March 14, 2022
Approval was based on results of the phase 3 OlympiA trial.
March 02, 2022
Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.
February 25, 2022
A recent study investigated how the limited access to specialty care in these populations may affect the detection and diagnosis of skin cancer.
February 23, 2022
Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
February 17, 2022
Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.
February 16, 2022
Patients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.
February 14, 2022
Jenny Sherak, president of Specialty Physician Services at AmerisourceBergen sat down with Drug Topics® to discuss how her team provides the best customer experiences for community oncology practices across the United States.
February 08, 2022
President Biden is reviving the program he headed as vice president, with the goal of reducing the cancer mortality rate and improving the experience of patients and their loved ones.